Global programs succeed less on plans and more on alignment. Governance, communication, and early risk visibility drive execution across complex stakeholder networks today.
- The Post-American Supply Chain: Navigating The New Multipolar Clinical Landscape
- Building Resilient Clinical Supply Chains In An Era Of Global Disruption
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- Forecast Vs. Actual: Why Protocol Design Breaks Clinical Supply Plans
- AI In Clinical Trial Supply Chains
- Clinical Trial Supply Lessons From Ebola Outbreak Response
- Global Labeling And Packaging In Complex Supply Environments
- Addressing Reverse Logistics In Clinical Supply Chains: Turning Complexity Into Strategic Advantage
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Running Decentralized Trials At Scale
As the industry continues to embrace decentralized approaches, sponsors are recognizing the potential benefits of DCTs, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
-
A Practical Packaging Components Checklist For Emerging Biotechs
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
Vial Containment Systems For Gene And Cell Therapies
CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
Overcoming Cell Therapy Supply Chain Challenges
For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
-
Optimizing Clinical Trials In China With Strategic Solutions For Supply Chain
Plan proactively for clinical trials in China by aligning with National Medical Products Administration requirements and leveraging Free Trade Zones to streamline regulatory approvals and clinical supply importation.
-
Is Your Clinical Supply Chain Fully Optimized?
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
Complex Randomization Delivered Successfully
Learn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
Enhancing Clinical IP Efficiency & Compliance
A U.S.-based clinical research sponsor optimized their supply chain visibility, reduced costs and risks, and improved efficiency by replacing their manual inventory management system.
-
Clinical Manufacturing: What It Is And How It Works
Clinical manufacturing is a specialized form of pharmaceutical manufacturing focused on producing drugs for clinical research. How does it work and how is it different from commercial manufacturing?
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.